Fennec Pharmaceuticals Inc (FENC)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 1.54M | 1.68M | 3.33M | 6.52M | 9.74M | 25.38M | 7.26M | 6.97M |
営業利益 | -6.28M | -5.27M | -4.67M | -1.02M | -1.82M | 13.74M | -5.04M | -5.2M |
税引前収入 | -6.86M | -6.05M | -5.44M | -1.87M | -2.68M | 12.84M | -5.55M | -5.74M |
純利益 | -6.86M | -6.05M | -5.44M | -1.87M | -2.68M | 12.84M | -5.55M | -5.74M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -6.28M | -5.27M | -4.67M | -1.02M | -1.82M | 13.74M | -5.04M | -5.2M |
EBITDA | -6.28M | -5.27M | -4.67M | -1.02M | -1.82M | 13.74M | -5.04M | -5.2M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 170k | 0 | 1.54M | 21.25M |
営業利益 | -2.87M | -6.95M | -10.41M | -13.01M | -17.89M | -17.22M | -22.74M | -12.77M |
税引前収入 | -2.79M | -7.05M | -9.89M | -12.78M | -18.11M | -17.35M | -23.71M | -16.05M |
純利益 | -2.79M | -7.05M | -9.89M | -12.78M | -18.11M | -17.35M | -23.71M | -16.05M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.204 | -0.383 | -0.497 | -0.642 | -0.696 | -0.667 | -0.9 | -0.594 |
EBIT | -2.85M | -6.96M | -10.4M | -13.03M | -17.89M | -17.22M | -22.74M | -12.77M |
EBITDA | -2.87M | -6.95M | -10.41M | -13.01M | -17.89M | -17.22M | -22.74M | -12.77M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約